Patents
US 7928092 B2: Formulations and methods of treating inflammatory bowel disease
- Granted
- 2011-04-19
- Filed
- 2010-06-10 application 12797655
- Type
- Utility · 9 claims
- Elsewhere
- Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗
Abstract
Methods and formulations for treating inflammatory bowel disease are disclosed. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of 4-aminosalicylic acid and/or 5-aminosalicylic acid to affected areas of the intestine. The methods and formulations comprise modified-release elements, providing for drug delivery to the affected or desired area. Diseases and conditions treatable with the present invention include Crohn's disease and ulcerative colitis.
Source: PVGPATDIS, file of 2026-04-10 (ipg110419.xml).
Assignees
| Assignee | Type | Place | Also on furp.org | Source |
|---|---|---|---|---|
| AGI Therapeutics Limited 1 patents | Not reported | Athlone, IE | PVGPATDIS, file of 2026-04-10 |
Inventors
| Inventor | Place | Patents | Person page | Source |
|---|---|---|---|---|
| John Devane | Athlone, IE | 16 | PVGPATDIS, file of 2026-04-10 | |
| Jackie Butler | Athlone, IE | 1 | PVGPATDIS, file of 2026-04-10 |
CPC categories
| Subclass | Category | First group | Source |
|---|---|---|---|
| A61K | Preparations for medical, dental or toiletry purposes | A61K9/2059 | PVGPATDIS, file of 2026-04-10 |
| A61P | Specific therapeutic activity of chemical compounds or medicinal preparations | A61P1/00 | PVGPATDIS, file of 2026-04-10 |
| C07C | Acyclic or carbocyclic compounds | C07C245/08 | PVGPATDIS, file of 2026-04-10 |
Cooperative Patent Classification, as currently assigned (one row per subclass).
Assignments and security interests
| Recorded | What | From | To | Reel/frame | Source |
|---|---|---|---|---|---|
| 2018-02-22 | Correction Corrective assignment to correct the us patent no. 8,050,873 previously recorded on reel 040183 frame 0129. assignor(s) hereby confirms the assignment. | WARNER CHILCOTT COMPANY, LLC signed 2015-12-31 | ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED DUBLIN 17 | 45417/593 | PASDL, file of 2026-10-15 |
| 2016-09-29 | Assignment Assignment of assignor's interest | WARNER CHILCOTT COMPANY, LLC signed 2015-12-31 | ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED DUBLIN 17 | 40183/129 | PASDL, file of 2026-10-15 |
| 2011-09-15 | Assignment Assignment of assignor's interest | AGI THERAPEUTICS LTD. signed 2011-07-21 | WARNER CHILCOTT COMPANY, LLC FAJARDO, PR | 26909/548 | ECORSEXC, file of 2026-09-25 |
Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.
USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.